New HBV Infection Biomarkers: Clinical Characterization and Impact on Management — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

New HBV Infection Biomarkers: Clinical Characterization and Impact on Management — Stella

Home/Chronic Hepatitis B Virus (HBV) Infection/

View on ClinicalTrials.gov

Recruiting

Back to Chronic Hepatitis B Virus (HBV) Infection trials

Trial locations(1 site)

France

Clinical Research Unit (CRU) Henri Mondor., Créteil, Créteil

Key details

Sponsor

Assistance Publique - Hôpitaux de Paris

Enrollment target

~900 participants

Started

November 2023

Primary completion

November 2038

Age range

18 Years and older

Last updated April 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.